Purchase Solution

Developing Drugs

Not what you're looking for?

Ask Custom Question

Do you believe the current system of protecting newly developed drugs for seven years from going generic and thus allowing the pharmaceutical company that developed it to charge prices that not only cover the research and FDA approval processes but also create reserves that cover legal suits, failed research, failed approval processes and company profit?

Simply put: are you willing to pay more for current drugs to insure the development of even new drugs?

Purchase this Solution
Solution Preview

Absolutely I am! Without it a major reason (not the only one but a VERY important one) for developing new drugs would disappear! To develop new drugs is a most costly (REALLY EXPENSIVE), uncertain, potentially dangerous, complicated and time consuming business so the profit motive is very much needed to urge the industry to produce new drugs. Without it most certainly much fewer new drugs would be developed and we would ALL suffer from that. It is a fact that during the 70 years or so of communism/socialism (no profit mechanism) in the Soviet Union (a ...

Purchase this Solution
Free BrainMass Quizzes
Celiac Disease

This quiz will provide a brief introduction to Celiac Disease. Questions will focus on definitions and symptoms.

Managed Care Organizations

This quiz will test the basics of managed care organizations. It is important to know how our health care delivery system operates through managed care.

Labor and Delivery

Do you know about the stages of delivery? Find out with this quiz!

Vitals about a Patient's Vitals

Basic questions about blood pressure and measurements.

First Aid

Do you know how to provide first aid?

View More Free Quizzes
Related BrainMass Solutions

  • Generic drugs and pharmaceutical costs

    While generic drugs are invaluable to developing countries and low income households, a balance between providing affordable drugs and not stifling research and development on new drugs.

  • The wholesale acquisition cost methodology

    Developing an effective generic prescription drug program. Benefits Quarterly, 19(1): 14-18.

  • Ethical dilemmas for drug companies

    Drugs and vaccines for developing countries. Retrieved from https://faculty.fuqua.duke.edu/~dbr1/research/developing-Oxford.pdf 3. Cockburn, I. M. (n.d).

  • Pharmaceutical Companies

    In poor developing nations such as India, these companies have been required to provide medicines for pennies on the dollar as this is the only way that poor in developing nations can have access to life-saving drugs such as HIV treatment.

  • Relevant financial information for investors

    558102 Relevant financial information for investors Assume there is a well-financed, one-year-old company in the biotech industry that is concentrating on developing chemical-based compounds that are aimed at developing drugs to reduce the effects or

  • Antibiotic development and resistance

    - Developing specific pumps that would actively remove drugs from the bacterial cells. - Developing enzymes that would be able to destroy or inactivate antimicrobials using processed such as hydrolyzation or methylation.

  • Eli Lilly Case Questions

    This also considers the quality factor which needs to be ensured while developing the efficient and effective drugs for the human.

  • Pros and Cons of FDA Process for Follow-On Biologics

    The expert discusses the pros and cons of FDA developing an AnDA- like process for "follow-on" biologics.

  • Patent - Effective Drugs for AIDS

    And most important of all, it will discourage pharmaceutical manufacturers in developed countries from developing new and more effective drugs.

View More Related Solutions